Pain, During Injection of Propofol for Induction of AnesthesiaNCT05898061
Optimal Lidocaine Propofol Mixture for Painless Induction of Anesthesia
An observational study of Pain, During Injection of Propofol for Induction of Anesthesia, run by Sohag University at 1 site in Egypt.
Trial summary
This research will be carried out in order to determine the optimal lidocaine dose in propofol lidocaine mixture to prevent pain on propofol injection during induction of general anesthesia using a modified Dixon's up-and-down method. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Pain, During Injection of Propofol for Induction of Anesthesia
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Mar 2023to 1 Dec 2023
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Study population: Patients scheduled for elective surgery under general anesthesia, aged 18 to 60 years and American Society of Anesthesiologists physical status I \& II will be selected for this study.
Who may be able to join
- Patients scheduled for elective surgery under general anesthesia.
- Aged 18 to 60 years
- American Society of Anesthesiologists physical status I \& II
Who cannot join
- History of drug allergy
- Hepatic or renal impairment .Cardiac disease
- Neurologic deficits ,psychiatric disorders
- Anxious patients who need sedation preoperatively
Trial locations and contacts
1 site in 1 country.
Fawzy A Badawy, MD contact
Egypt1 site, 1 recruiting
- Recruiting
Sohag University Hospital
Sohag
Magdy M Amim, Professor
About this study
This research will be carried out in order to determine the optimal lidocaine dose in propofol lidocaine mixture to prevent pain on propofol injection during induction of general anesthesia using a modified Dixon's up-and-down method. Patients \& methods: Include assessment of severity of pain on propofol injection using seven doses of lidocaine in lidocaine propofol mixture in ASA I\&II patients aged 18-60 years with exclusion of patients with history of drug allergy, hepatic or renal impairment, cardiac problems, neurologic deficits or psychiatric disorders.
The primary outcome will be pain scale during injection and volume of propofol-lidocaine mixture used. Secondary outcome will be increase in heart rate and/or hand or forearm withdrawal during injection, patient satisfaction, demographic data, type and duration of surgery, Time for unconsciousness.
Aim of the work: To determine the Minimal effective dose of lidocaine in propofol lidocaine mixture to achieve painless induction of anesthesia using propofol.
Read the detailed description
Rapid onset of action, smooth induction, favorable recovery and low rate of adverse effects have made propofol the most commonly used intravenous anesthetic for induction and maintenance of anesthesia. However, pain associated with propofol injection is still considered by many patients as the worst prioperative unpleasant experience.1 Therefore, a diversity of techniques have been suggested in the literature to solve this problem including pretreatment with local anesthetics, opiates, ketamine and alfentanil. 2-5 New propofol formulation was another way to alleviate this pain.6 Among these techniques lidocaine was investigated extensively whether as a pretreatment with the use of tourniquet, which is a time consuming technique, or mixed with propofol. Evaluation of optimal dose of lidocaine in propofol lidocaine mixture was widely assessed. However, evaluation of optimal lidocaine dose in propofol lidocaine mixture to prevent pain with newer formulations of propofol should be further evaluated. We hypothesize that optimal dose of lidocaine to alleviate pain with propofol injection might need further evaluation.
Patients and methods
This prospective randomized and double blinded study will be conducted in Sohag University Hospital after obtaining approval from Institutional Review Board and written informed consent from all patients before enrolment in this study. Patients scheduled for elective surgery under general anesthesia, aged 18 to 60 years and American Society of Anesthesiologists (ASA)physical status I \& II will be selected for this study. Patients with history of drug allergy, hepatic or renal impairment, cardiac problems, neurologic deficits, psychiatric disorders or anxious patients who need sedation preoperatively will be excluded from the study.
Before entering the operating room premedication will not be allowed. In the operating room 20 gauge cannula will be inserted into a vein on the dorsum of the non-dominant hand \& basic monitoring (pulse oximetry, electrocardiography, noninvasive blood pressure \& end tidal carbon dioxide) will be applied to the patient before induction and throughout the procedure.
Mixtures of propofol, lidocaine and saline will be prepared by an anesthetist who is not involved in the study team according to the lidocaine dose sequence as shown in table (1) resulting into eight mixtures. The mixture will be injected at a rate of 20ml/minute using syringe pump until patient loose consciousness. The anesthetist who inject the propofol and the patient will be blinded to the lidocaine dose in the mixture.
Table 1 propofol lidocaine mixtures Mixture Propofol Lidocaine 2% (ml)(20mg/ml) Lidocaine concentration (%)
- 20ml 0.5
- 20ml 1 0.095
- 20ml 1.5 0.139
- 20ml 2 0.181
- 20ml 2.5 0.222
- 20ml 3 0.26
- 20ml 3.5 0.297
- 20ml 4 0.333
Pain scale will be explained to all patients preoperatively and they will be asked to report for pain sensation (no pain or mild, moderate or severe pain) The dose of lidocaine, in propofol lidocaine mixture, administered to each patient will be determined by the response of the previous patient using a modified Dixon's up-and-down method (using 10mg as a step size). The first patient will receive a mixture with 10mg lidocaine. If the patient report pain with propofol injection, then the next patient will receive a mixture with 10mg higher dose of lidocaine, if the patient report no pain with injection, then the next patient will receive a mixture with 10mg lower dose of lidocaine. The study will continue until we obtain seven crossover midpoints (No limited number).
The minimal effective dose of lidocaine that results in painless injection of propofol for 50% (ED50) of patients will be determined by calculating the midpoint dose of all independent pairs of patients after at least seven crossover points.
The following data will be recorded; Primary outcome: pain scale during injection and volume of propofol-lidocaine mixture used.
Secondary outcome: increase in heart rate and/or hand or forearm withdrawal during injection, patient satisfaction(will be assessed in the post anesthesia care unit (PACU) after regaining consciousness), demographic data, type and duration of surgery, Time for unconsciousness.
Aim of the work To determine the Minimal effective dose of lidocaine in propofol lidocaine mixture to achieve painless induction of anesthesia using propofol.
- Keywords
- Propofol - Lidocaine - Painless Induction
- Medical subject headings
- Pain
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain scale
Pain scale (mild, moderate or severe) during injection of propofol
Measured: 9 months
Secondary outcomes (4)
Heart rate
Heart rate
Measured: Before injection of propofol-lidocaine mixture and every minute for three minutes after start of injection
time for unconsciousness
time in seconds starting from injection of Propofol-lidocaine mixture until patient loose consciousness
Measured: 2 minutes after start of injection of propofol
patient satisfaction
describes satisfaction level of the patient regarding relief of propofol injection (not satisfied, less satisfied, satisfied, highly satisfied)
Measured: 30 minutes after recovery
hand or forearm withdrawal
withdrawal due to pain during injection of propofol
Measured: 2 minutes duration during injection of propofol
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2023
- Study start1 Mar 2023
- Primary completion1 Dec 2023 (estimated)
- Study completion1 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Pain, During Injection of Propofol for Induction of AnesthesiaStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Fawzy Abbas Badawy, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05898061
- Sponsor's protocol ID
- Soh-Med-22-11-15
- Status last verified
- Jun 2023
- First submitted
- 30 Apr 2023
- Last updated
- 12 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Lembert N, Wodey E, Geslot D, Ecoffey C. [Prevention of pain on injection with propofol in children: comparison of nitrous oxide with lidocaine]. Ann Fr Anesth Reanim. 2002 Apr;21(4):263-70. doi: 10.1016/s0750-7658(02)00588-9. French.
PubMed 12033094Zahedi H, Nikooseresht M, Seifrabie M. Prevention of propofol injection pain with small-dose ketamine. Middle East J Anaesthesiol. 2009 Oct;20(3):401-4.
PubMed 19950734Iyilikci L, Balkan BK, Gokel E, Gunerli A, Ellidokuz H. The effects of alfentanil or remifentanil pretreatment on propofol injection pain. J Clin Anesth. 2004 Nov;16(7):499-502. doi: 10.1016/j.jclinane.2004.01.005.
PubMed 15590252Kobayashi Y, Naganuma R, Seki S, Aketa K, Ichimiya T, Namiki A. [Reduction of pain on injection of propofol: a comparison of fentanyl with lidocaine]. Masui. 1998 Aug;47(8):963-7. Japanese.
PubMed 9753961
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Optimal Lidocaine Propofol Mixture for Painless Induction of Anesthesia
- ClinicalTrials.gov ID
- NCT05898061
- Acronym / sponsor ID
- Soh-Med-22-11-15
- Keywords
- Propofol - Lidocaine - Painless Induction
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Mar 2023 (actual)
- Primary completion
- 1 Dec 2023 (estimated)
- Study completion
- 1 Dec 2023 (estimated)
- First posted
- 12 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research will be carried out in order to determine the optimal lidocaine dose in propofol lidocaine mixture to prevent pain on propofol injection during induction of general anesthesia using a modified Dixon's up-and-down method. Patients \& methods: Include assessment of severity of pain on propofol injection using seven doses of lidocaine in lidocaine propofol mixture in ASA I\&II patients aged 18-60 years with exclusion of patients with history of drug allergy, hepatic or renal impairment, cardiac problems, neurologic deficits or psychiatric disorders.
The primary outcome will be pain scale during injection and volume of propofol-lidocaine mixture used. Secondary outcome will be increase in heart rate and/or hand or forearm withdrawal during injection, patient satisfaction, demographic data, type and duration of surgery, Time for unconsciousness.
Aim of the work: To determine the Minimal effective dose of lidocaine in propofol lidocaine mixture to achieve painless induction of anesthesia using propofol.
Detailed description
Rapid onset of action, smooth induction, favorable recovery and low rate of adverse effects have made propofol the most commonly used intravenous anesthetic for induction and maintenance of anesthesia. However, pain associated with propofol injection is still considered by many patients as the worst prioperative unpleasant experience.1 Therefore, a diversity of techniques have been suggested in the literature to solve this problem including pretreatment with local anesthetics, opiates, ketamine and alfentanil. 2-5 New propofol formulation was another way to alleviate this pain.6 Among these techniques lidocaine was investigated extensively whether as a pretreatment with the use of tourniquet, which is a time consuming technique, or mixed with propofol. Evaluation of optimal dose of lidocaine in propofol lidocaine mixture was widely assessed. However, evaluation of optimal lidocaine dose in propofol lidocaine mixture to prevent pain with newer formulations of propofol should be further evaluated. We hypothesize that optimal dose of lidocaine to alleviate pain with propofol injection might need further evaluation.
Patients and methods
This prospective randomized and double blinded study will be conducted in Sohag University Hospital after obtaining approval from Institutional Review Board and written informed consent from all patients before enrolment in this study. Patients scheduled for elective surgery under general anesthesia, aged 18 to 60 years and American Society of Anesthesiologists (ASA)physical status I \& II will be selected for this study. Patients with history of drug allergy, hepatic or renal impairment, cardiac problems, neurologic deficits, psychiatric disorders or anxious patients who need sedation preoperatively will be excluded from the study.
Before entering the operating room premedication will not be allowed. In the operating room 20 gauge cannula will be inserted into a vein on the dorsum of the non-dominant hand \& basic monitoring (pulse oximetry, electrocardiography, noninvasive blood pressure \& end tidal carbon dioxide) will be applied to the patient before induction and throughout the procedure.
Mixtures of propofol, lidocaine and saline will be prepared by an anesthetist who is not involved in the study team according to the lidocaine dose sequence as shown in table (1) resulting into eight mixtures. The mixture will be injected at a rate of 20ml/minute using syringe pump until patient loose consciousness. The anesthetist who inject the propofol and the patient will be blinded to the lidocaine dose in the mixture.
Table 1 propofol lidocaine mixtures Mixture Propofol Lidocaine 2% (ml)(20mg/ml) Lidocaine concentration (%)
- 20ml 0.5
- 20ml 1 0.095
- 20ml 1.5 0.139
- 20ml 2 0.181
- 20ml 2.5 0.222
- 20ml 3 0.26
- 20ml 3.5 0.297
- 20ml 4 0.333
Pain scale will be explained to all patients preoperatively and they will be asked to report for pain sensation (no pain or mild, moderate or severe pain) The dose of lidocaine, in propofol lidocaine mixture, administered to each patient will be determined by the response of the previous patient using a modified Dixon's up-and-down method (using 10mg as a step size). The first patient will receive a mixture with 10mg lidocaine. If the patient report pain with propofol injection, then the next patient will receive a mixture with 10mg higher dose of lidocaine, if the patient report no pain with injection, then the next patient will receive a mixture with 10mg lower dose of lidocaine. The study will continue until we obtain seven crossover midpoints (No limited number).
The minimal effective dose of lidocaine that results in painless injection of propofol for 50% (ED50) of patients will be determined by calculating the midpoint dose of all independent pairs of patients after at least seven crossover points.
The following data will be recorded; Primary outcome: pain scale during injection and volume of propofol-lidocaine mixture used.
Secondary outcome: increase in heart rate and/or hand or forearm withdrawal during injection, patient satisfaction(will be assessed in the post anesthesia care unit (PACU) after regaining consciousness), demographic data, type and duration of surgery, Time for unconsciousness.
Aim of the work To determine the Minimal effective dose of lidocaine in propofol lidocaine mixture to achieve painless induction of anesthesia using propofol.
Study design
- Observational model
- Case crossover
- Time perspective
- Prospective
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Patients scheduled for elective surgery under general anesthesia, aged 18 to 60 years and American Society of Anesthesiologists physical status I \& II will be selected for this study.
Key inclusion criteria (3 listed)
- Patients scheduled for elective surgery under general anesthesia.
- Aged 18 to 60 years
- American Society of Anesthesiologists physical status I \& II
Key exclusion criteria (4 listed)
- History of drug allergy
- Hepatic or renal impairment .Cardiac disease
- Neurologic deficits ,psychiatric disorders
- Anxious patients who need sedation preoperatively
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Pain scale
Time frame: 9 months
Pain scale (mild, moderate or severe) during injection of propofol
4 secondary outcomes
Heart rate
Time frame: Before injection of propofol-lidocaine mixture and every minute for three minutes after start of injection
time for unconsciousness
Time frame: 2 minutes after start of injection of propofol
patient satisfaction
Time frame: 30 minutes after recovery
hand or forearm withdrawal
Time frame: 2 minutes duration during injection of propofol
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2023.
- Background: PubMed 12033094Lembert N, Wodey E, Geslot D, Ecoffey C. [Prevention of pain on injection with propofol in children: comparison of nitrous oxide with lidocaine]. Ann Fr Anesth Reanim. 2002 Apr;21(4):263-70. doi: 10.1016/s0750-7658(02)00588-9. French.
- Background: PubMed 19950734Zahedi H, Nikooseresht M, Seifrabie M. Prevention of propofol injection pain with small-dose ketamine. Middle East J Anaesthesiol. 2009 Oct;20(3):401-4.
- Background: PubMed 15590252Iyilikci L, Balkan BK, Gokel E, Gunerli A, Ellidokuz H. The effects of alfentanil or remifentanil pretreatment on propofol injection pain. J Clin Anesth. 2004 Nov;16(7):499-502. doi: 10.1016/j.jclinane.2004.01.005.
- Background: PubMed 9753961Kobayashi Y, Naganuma R, Seki S, Aketa K, Ichimiya T, Namiki A. [Reduction of pain on injection of propofol: a comparison of fentanyl with lidocaine]. Masui. 1998 Aug;47(8):963-7. Japanese.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fawzy A Badawy, MD contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pain, During Injection of Propofol for Induction of Anesthesia, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 12 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Fawzy A Badawy, MD (00201004862474, fawzy_saleem@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain scale (time frame: 9 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05898061, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2023.